Polymerase Chain Reaction Market to Grow by 3X Due to Extensive Application for COVID-19 Testing

A recent study by Fact.MR on the polymerase chain reaction market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging associated with the manufacturing of polymerase chain reaction products.

Demand for polymerase chain reaction tests is anticipated to reach US$ 3.6 Billion by 2021-end, further expanding to US$ 12 Billion at the conclusion of the 2021-2031 assessment period, according to a recent report published by Fact.MR. The market is poised to expand 3x, with PCR reagents set to capture 60% of total revenue.

Key Takeaways from the Market Study

  • PCR reagents anticipated to capture 3/5th of global market demand until 2031
  • Pharmaceutical & biotechnology industry to be primary end user, registering a CAGR of 8.6%
  • Clinical diagnostic labs & hospitals to register a CAGR of approximately 9%
  • North America to generate 46.2% market revenue for polymerase chain reaction
  • Asia to be the fastest growing market, registering a CAGR worth 9.7% through 2031

Request Sample Report

“Rise in the prevalence of chronic and infectious diseases is projected to push the demand for PCR solutions during the forecast period,” comments a Fact.MR analyst

Key Companies Profiled in Polymerase Chain Reaction Market

  • Bio-Rad Laboratories Inc.
  • Qiagen N.V
  • Roche Diagnostics
  • Becton Dickinson & Company (BD)
  • Abbott Laboratories
  • Siemens Healthineers
  • BioMerieux S.A
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies

Key Segments Covered

  • Product
    • PCR Instruments
    • Standard PCR Systems
    • RT PCR Systems
    • Digital PCR Systems
    • PCR Reagents
    • PCR Consumables
  • End User
    • PCR for Pharmaceutical & Biotechnology Industries
    • PCR for Clinical Diagnostics Labs and Hospitals
    • PCR for Academic and Research Organizations
    • PCR for Other End Users

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the polymerase chain reaction market, presenting historical demand data (2016-2020) and forecast statistics from 2021 to 2031.

The study divulges essential insights on the market based on product (instruments, standard PCR systems, RT PCR systems, digital PCR systems, reagents and consumables) and end user (pharmaceutical & biotechnology industries, clinical diagnostics labs and hospitals, academic and research organizations and others) across seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Leave a Reply